Despite a critical role of BCR signal in CLL cell proliferation and survival, CLL cells also overexpress multiple constitutively active receptor tyrosine kinases (RTKs) including AXL [17] and its downstream target, FGFR3 (Figure 4D) [18]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.